Sept 22 (Reuters) - Bristol Myers Squibb (BMY.N), opens new tab (BMS) plans to launch schizophrenia drug Cobenfy in the UK next year at a price matching its U.S. list price, it said on Monday. Cobenfy ...
Sept 29 (Reuters) - AbbVie (ABBV.N), opens new tab said on Monday it would launch its ovarian cancer drug Elahere in the UK at a list price matching that in the U.S. President Donald Trump has been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback